FDA Panel Backs Moderna’s Novel mRNA Flu Shot for Older Americans
Federal vaccine advisors gave Moderna’s mRNA flu shot, called mFlusiva or mRNA 1010, a major boost Thursday.The Food and Drug Administration’s (FDA) expert panel, Vaccines and Related Biological Products Advisory Committee (VRBPAC), accepted…